Even when good scientific data are available, people’s interpretation of risks and benefits will differ
The power and influence of healthcare systems comes largely from the ability to prescribe efficaciou...
Drug safety continues to be a major public health concern in the United States, with adverse drug re...
Risk-benefit assessment for decision-making based on evidence is a subject of continuing interest. H...
Even when good scientific data are available, people's interpretation of risks and benefits will dif...
Medication-related adverse events are a major cause of disability and death,1 and one of the most co...
The issues of weighing benefits and harms and of shared decision-making have become increasingly imp...
Objectives: To compare the effects of two types of information, prevention and response, presented i...
Part I of this Article evaluates the pre-approval and post-approval regulatory framework governing p...
The objective of this study is to assess how both the severity of illness and the probability of sid...
Regulatory agencies approve drugs for marketing when the ratio of risk to benefit of the drugs is po...
Evidence-based medicine has gained mainstream popularity, but it requires a delicate balance between...
Benefit-risk assessment should be ongoing during the life cycle of a pharmaceutical agent. New produ...
Paper presented at the 1st International Symposium on Understanding Health Benefits and Risks: Empow...
This paper presents findings from case studies of health consumers who each suspect they may have ex...
Joint evaluation of drugs’ beneficial and adverse effects is required in many situations, in particu...
The power and influence of healthcare systems comes largely from the ability to prescribe efficaciou...
Drug safety continues to be a major public health concern in the United States, with adverse drug re...
Risk-benefit assessment for decision-making based on evidence is a subject of continuing interest. H...
Even when good scientific data are available, people's interpretation of risks and benefits will dif...
Medication-related adverse events are a major cause of disability and death,1 and one of the most co...
The issues of weighing benefits and harms and of shared decision-making have become increasingly imp...
Objectives: To compare the effects of two types of information, prevention and response, presented i...
Part I of this Article evaluates the pre-approval and post-approval regulatory framework governing p...
The objective of this study is to assess how both the severity of illness and the probability of sid...
Regulatory agencies approve drugs for marketing when the ratio of risk to benefit of the drugs is po...
Evidence-based medicine has gained mainstream popularity, but it requires a delicate balance between...
Benefit-risk assessment should be ongoing during the life cycle of a pharmaceutical agent. New produ...
Paper presented at the 1st International Symposium on Understanding Health Benefits and Risks: Empow...
This paper presents findings from case studies of health consumers who each suspect they may have ex...
Joint evaluation of drugs’ beneficial and adverse effects is required in many situations, in particu...
The power and influence of healthcare systems comes largely from the ability to prescribe efficaciou...
Drug safety continues to be a major public health concern in the United States, with adverse drug re...
Risk-benefit assessment for decision-making based on evidence is a subject of continuing interest. H...
DOI
Add to ORKG